| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9624 |
| Human Intestinal Absorption | HIA+ | 0.9436 |
| Caco-2 Permeability | Caco2+ | 0.6505 |
| P-glycoprotein Substrate | Non-substrate | 0.8690 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9785 |
| Non-inhibitor | 0.9835 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9239 |
| Distribution |
| Subcellular localization | Lysosome | 0.4689 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8203 |
| CYP450 2D6 Substrate | Non-substrate | 0.8890 |
| CYP450 3A4 Substrate | Non-substrate | 0.8149 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.7991 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9121 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9416 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9066 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9734 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9461 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9380 |
| Non-inhibitor | 0.9706 |
| AMES Toxicity | Non AMES toxic | 0.7897 |
| Carcinogens | Carcinogens | 0.6445 |
| Fish Toxicity | Low FHMT | 0.8625 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.5378 |
| Honey Bee Toxicity | High HBT | 0.7814 |
| Biodegradation | Ready biodegradable | 0.7239 |
| Acute Oral Toxicity | II | 0.4302 |
| Carcinogenicity (Three-class) | Non-required | 0.6219 |